Shree Hari Chemicals board re-appoints CMD and adds independent director

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Board re-appointed CMD Bankesh Chandra Agrawal and WTDs Sarthak and Nihit Agarwal for three-year terms
  • Independent Director Shri Ram Gupta re-appointed for a second five-year term starting September 29, 2026
  • Amrut Urkude appointed as additional independent director effective August 25, 2026
  • All appointments require shareholder approval under SEBI LODR Regulations
powered bylight_fuzz_icon
49218587

*this image is generated using AI for illustrative purposes only.

Shree Hari Chemicals Export Limited’s Board of Directors held a meeting on August 25, 2026, to approve the re-appointment of its Chairman & Managing Director and two Whole Time Directors for three-year terms. The board also appointed an additional independent director.

The approvals are subject to shareholder consent. All appointments align with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Key Appointments

The board considered and approved the following changes to its composition:

Director Role Term Start Duration
Bankesh Chandra Agrawal Chairman & Managing Director November 11, 2026 Three years
Sarthak Agarwal Whole Time Director November 11, 2026 Three years
Nihit Agrawal Whole Time Director November 11, 2026 Three years
Shri Ram Gupta Independent Director September 29, 2026 Five years (second term)
Amrut Urkude Additional Independent Director August 25, 2026 Five years

Bankesh Chandra Agrawal, 74, brings over 49 years of experience in the yarn and chemical industries. Sarthak Agarwal, 34, has more than 13 years of experience in textile and chemical business. Nihit Agarwal, 32, holds a B.Tech degree and has over 10 years of industry experience.

Shri Ram Gupta, 70, is a Chartered Accountant with 44 years of experience in finance, banking, and taxation. Amrut Urkude, 54, holds a Doctorate in Management Studies and has over 30 years of experience in corporate governance and organizational leadership.

Governance Disclosures

The filing confirms that none of the directors have been debarred from holding office by SEBI or any other authority. Relationships between directors were disclosed as follows:

  • Bankesh Chandra Agrawal, Sarthak Agarwal, Nihit Agarwal, and Non-executive Director Vikas Agarwal are related.
  • Shri Ram Gupta and Amrut Urkude are not related to promoters or other directors.

The board meeting commenced at 12:15 pm and concluded at 6:00 pm.

Historical Stock Returns for Shree Hari Chemicals Export

1 Day5 Days1 Month6 Months1 Year5 Years
+4.99%-0.27%+62.40%+177.10%+189.08%+372.56%

How might the re-appointment of the Agarwal family members influence Shree Hari Chemicals' strategic direction and succession planning over the next three years?

What specific expertise does the newly appointed independent director, Amrut Urkude, bring that could enhance the company's corporate governance or risk management frameworks?

Will the upcoming shareholder vote on these appointments signal any potential dissent regarding the current board composition or management structure?

Shree Hari Chemicals Export
View Company Insights
View All News
like15
dislike

Shree Hari Chemicals FY26 Revenue Rises, Net Profit Declines

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

Shree Hari Chemicals Export Limited reported its audited financial results for FY26, showing a rise in standalone revenue to Rs. 18,450.48 lakhs from Rs. 14,119.58 lakhs in the previous year. However, standalone net profit declined to Rs. 422.22 lakhs from Rs. 512.40 lakhs. On a consolidated basis, total income reached Rs. 18,763.84 lakhs with a net profit of Rs. 411.81 lakhs. The company confirmed no deviations in preferential issue utilization and reported outstanding qualified borrowings of Rs. 28.38 crores.

powered bylight_fuzz_icon
40399518

*this image is generated using AI for illustrative purposes only.

Shree Hari Chemicals Export Limited's Board of Directors approved the audited standalone and consolidated financial statements for the year ended March 31, 2026. The results were reviewed by the Audit Committee and received an unmodified opinion from auditors Kailash Chand Jain & Co.

Standalone Financial Performance

On a standalone basis, the company recorded revenue from operations of Rs. 18,450.48 lakhs for FY26, compared to Rs. 14,119.58 lakhs in FY25. Total income stood at Rs. 18,756.27 lakhs. Net profit for the year declined to Rs. 422.22 lakhs from Rs. 512.40 lakhs in the previous year. Total comprehensive income for FY26 was Rs. 421.01 lakhs.

Particulars FY26 (Audited) FY25 (Audited)
Revenue from Operations 18,450.48 14,119.58
Total Income 18,756.27 14,206.70
Total Expenses 18,226.69 13,511.20
Net Profit 422.22 512.40
Basic EPS (Rs.) 8.23 11.47

Consolidated Financial Performance

On a consolidated basis, total income for FY26 was Rs. 18,763.84 lakhs (FY25: Rs. 14,206.70 lakhs). Consolidated net profit was Rs. 411.81 lakhs versus Rs. 509.75 lakhs in FY25. Total comprehensive income attributable to owners was Rs. 410.61 lakhs.

Particulars FY26 (Audited) FY25 (Audited)
Revenue from Operations 18,450.48 14,119.58
Total Income 18,763.84 14,206.70
Net Profit 411.81 509.75
Basic EPS (Rs.) 8.03 11.41

Balance Sheet and Cash Flow

The standalone balance sheet as of March 31, 2026, reflects total assets of Rs. 10,242.83 lakhs, up from Rs. 8,662.52 lakhs. Equity share capital stood at Rs. 553.79 lakhs. The standalone cash flow statement shows cash generated from operating activities of Rs. 1,105.64 lakhs, compared to an outflow of Rs. (147.26) lakhs in the prior year. The closing cash balance was Rs. 55.37 lakhs.

Regulatory Disclosures

Pursuant to Regulation 32(1), the company confirmed no deviations in the utilization of proceeds from its Preferential Issue, which raised Rs. 14,74,59,820. Regarding the SEBI Circular on Large Corporates, outstanding qualified borrowings at the end of FY26 were Rs. 28.38 crores, with no incremental borrowing or debt securities issued during the year.

Historical Stock Returns for Shree Hari Chemicals Export

1 Day5 Days1 Month6 Months1 Year5 Years
+4.99%-0.27%+62.40%+177.10%+189.08%+372.56%

Given the significant increase in revenue but declining net profit margins in FY26, what cost optimization strategies is Shree Hari Chemicals Export likely to implement to restore profitability in FY27?

With capital work-in-progress nearly doubling to Rs. 764.88 lakhs and investments surging from Rs. 104.66 to Rs. 1,221.99 lakhs, what capacity expansion or diversification projects are underway and how might they impact future revenue growth?

How could rising current borrowings (up to Rs. 2,563.39 lakhs) combined with minimal cash reserves of Rs. 55.37 lakhs affect the company's ability to service debt and fund working capital requirements in FY27?

Shree Hari Chemicals Export
View Company Insights
View All News
like15
dislike

More News on Shree Hari Chemicals Export

1 Year Returns:+189.08%